Novozymes disappoints in Q3 earnings on 'weak sales'
October 26, 2016 at 02:40 AM EDT
"It's mainly due to bioenergy in the U.S. and the situation keeps deteriorating as our customers are living through a very difficult time," says CEO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.